Warren Slams Inhaler Manufacturer GlaxoSmithKline for Price-Gouging Patients and Making Inhalers Inaccessible for Children
March 04, 2024
March 04, 2024
WASHINGTON, March 4 -- Sen. Elizabeth Warren, D-Massachusetts, issued the following news release:
Big Pharma "company has made a life-saving drug inaccessible for millions of children just months before allergy season -- all to pad the profits of [GlaxoSmithKline's] executives and shareholders."
Letter Text (PDF)
Washington, D.C. - Today, U.S. Senator Elizabeth Warren (D-Mass.) blasted GlaxoSmithKline (GSK) for its price-gouging strategy that may . . .
Big Pharma "company has made a life-saving drug inaccessible for millions of children just months before allergy season -- all to pad the profits of [GlaxoSmithKline's] executives and shareholders."
Letter Text (PDF)
Washington, D.C. - Today, U.S. Senator Elizabeth Warren (D-Mass.) blasted GlaxoSmithKline (GSK) for its price-gouging strategy that may . . .